Physicochemical evaluation, GC–MS-based phytoconstituent analysis and network pharmacology study of Guduchi Arka: an ayurvedic hydro-distillate

Deepa Sharma , Ganesh Dane , Smriti Tandon , Chandrashekhar Jagtap , Vijay Kumar , Suman Mondal , Akanksha Thakur , Vaibhav Charde , Hemant Rawat , Ravi Nahar , Sanjeev Kumar Lale , B. S. Sharma , Shruti Khanduri , T. Maheshwar , N. Srikanth , Rabinarayan Acharya

Bioresources and Bioprocessing ›› 2026, Vol. 13 ›› Issue (1) : 146

PDF
Bioresources and Bioprocessing ›› 2026, Vol. 13 ›› Issue (1) :146 DOI: 10.1186/s40643-026-01127-z
Research
research-article
Physicochemical evaluation, GC–MS-based phytoconstituent analysis and network pharmacology study of Guduchi Arka: an ayurvedic hydro-distillate
Author information +
History +
PDF

Abstract

Guduchi Arka is a classical Ayurvedic hydro-distillate formulation with quick absorption and healing properties, prepared from Tinospora cordifolia (Willd.) Miers. Despite its long history of traditional use, the scientific community still lacks a complete set of quality parameters for its chemical composition and its molecular mechanisms. To overcome this problem, laboratory analysis and computer modelling parameters were used to investigate the quality, safety, and effectiveness of the formulation in treating fever and cold. Guduchi samples were obtained from three locations in India (Jhansi, Bengaluru, and Itanagar), and the raw materials were analysed to verify compliance with API standards. Authenticated Guduchi samples were processed arka preparation by using a standardised hydro-distillation method, and the resulting arka was assessed by physicochemical analysis, with a pH of 6.15–6.95, a specific gravity near 1.00, and an essential oil content of approximately 0.236%. Raw drugs and Arka preparations complied with standard API safety standards, as no pathogenic organisms were detected, heavy metals, pesticides, and aflatoxins were undetectable, and microbial content was below the standard API limit. GC–MS analysis of the arka formulation revealed a consistent and rich array of bioactive compounds, including 1-Eicosanol, α-Campholenal, o-toluric acid, Anethole, Estragole, Embelin, Nicolaioidesin A, (-)-Globulol, Paliclavine, and Chamazulene. To assess its therapeutic significance, 20 phytoconstituents of the Guduchi arka formulation were screened using network pharmacology and molecular docking. These compounds showed 248 overlapping targets with genes associated with fever and respiratory infections. The key regulatory proteins HSP90AA1, EGFR, and HSP90AB1 emerged as central nodes in the protein–protein interaction networks. To better validate the molecular docking study, robust biological interactions were observed: Nicolaiodesin A interacted effectively with EGFR (score: − 7.2 kcal/mol), whereas Embelin interacted effectively with HSP90AA1 (score: − 6.6 kcal/mol). Finally, this study demonstrates that Guduchi Arka is a highly standardised and safe formulation that retains all its healing phytochemicals during the distillation process. This study elucidates the mode of action of Guduchi Arka on immunity and inflammation, providing a solid scientific basis for its traditional use and future applications in herbal medicine.

Keywords

Amrita / Arka / Guduchi / Hydro-distillate / In-silico study / Network pharmacology

Cite this article

Download citation ▾
Deepa Sharma, Ganesh Dane, Smriti Tandon, Chandrashekhar Jagtap, Vijay Kumar, Suman Mondal, Akanksha Thakur, Vaibhav Charde, Hemant Rawat, Ravi Nahar, Sanjeev Kumar Lale, B. S. Sharma, Shruti Khanduri, T. Maheshwar, N. Srikanth, Rabinarayan Acharya. Physicochemical evaluation, GC–MS-based phytoconstituent analysis and network pharmacology study of Guduchi Arka: an ayurvedic hydro-distillate. Bioresources and Bioprocessing, 2026, 13 (1) : 146 DOI:10.1186/s40643-026-01127-z

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Arka Prakasha (Arkaprakāśa), Pandit Mukundram, Khemraj Shri Krishnadas (2019) Mumbai , Ch. 1 (Sloka 55–60), pp 13–14

[2]

Arka Prakasha (Arkaprakāśa), Pandit Mukundram, Khemraj Shri Krishnadas (2019) Mumbai, Ch. 2 (Sloka 3-8), pp 23-24

[3]

Acharya R, Sojitra NH, Buha MM. A comprehensive review of Guduchi (Tinospora cordifolia (Wild.) Miers), the ambrosia of Ayurveda: a classical memoir. Ann Ayurvedic Med, 2021, 102148164.

[4]

Ancy N, Sreekumar TD. Pharmaceutical and analytical study of Manjishtadi Arka. Int Res J Pharm Med Sci (IRJPMS), 2020, 366266

[5]

Bhosale HJ, Mamdapure SV, Panchal RB, Dhuldhaj UP. α-Amylase, α-glucosidase and aldose reductase inhibitory and molecular docking studies on Tinospora cordifolia (Guduchi) leaf extract. Future J Pharm Sci, 2024, 101107

[6]

Bishayi B, Roychowdhury S, Ghosh S, Sengupta M. Hepatoprotective and immunomodulatory properties of Tinospora cordifolia in CCl4 intoxicated mature albino rats. J Toxicol Sci, 2002, 273139146.

[7]

Chen L, Chu C, Lu J, Kong X, Huang T, Cai YD. Gene ontology and KEGG pathway enrichment analysis of a drug target-based classification system. PLoS ONE, 2015, 105p. e0126492

[8]

Chopra A, et al. Comparable efficacy of standardised Ayurveda formulation and hydroxychloroquine sulfate (HCQS) in the treatment of rheumatoid arthritis (RA): a randomised investigator-blind controlled study. Clin Rheumatol, 2011, 312259269.

[9]

Chow AW, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis, 2012, 54810411045.

[10]

Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol, 2015, 1263: 243-250.

[11]

Dane G, et al. Pharmaceutical and analytical standardisation of Varadi Kwatha Churna: an ayurvedic polyherbal formulation. Discov Appl Sci, 2026.

[12]

Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med, 2003, 1634487494.

[13]

Gandhi Y, Kushwaha V, Kumar V, Rawat H, Charde V, et al. Simultaneously quantification of eight marker compounds by HPLC, and HPTLC analysis for the marker-based shelf-life kinetic study for the standardization of polyherbal drug AYUSH SG-5. Microchem J, 2024.

[14]

GeneCards - The Human Gene Database. Accessed 25 July 2026. [Online]. Available: https://www.genecards.org/

[15]

Heikkinen T, Järvinen A. The common cold. Lancet, 2003, 36193515159.

[16]

Joy A, Acharya R. An inclusive review on Guduchi Satva: a distinctive drug dosage form of Ayurveda pharmaceutics. J Indian Syst Med, 2022.

[17]

Kim S, et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res, 2021, 49D1D1388D1395.

[18]

Minstry of Ayush (2008) The Ayurvedic Pharmacopoeia of India, Part-I Volume-VII (Pharmacognosy), 1st ed., vol. VII. Government of India Ministry of Health and Family Welfare Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy, New Delhi

[19]

Minstry of Ayush (2017a) The Ayurvedic Pharmacopeia of India, Vol. IV Part II, Appendix 2.2.8 (LOD), 1st ed., vol. Part II Volume IV. Pharmacopeial Commission for Indian Medicine and Homeopathy, Ghaziabad

[20]

Minstry of Ayush (2017e) The Ayurvedic Pharmacopeia of India, Vol. IV Part II Appendix 2.4 (Microbial), vol. Part II Vol IV. Pharmacopeial Commission for Indian Medicine and Homeopathy, Ghaziabad

[21]

Minstry of Ayush (2017b) The Ayurvedic Pharmacopeia of India, Vol. IV Part II Appendix 2.2.3 (Total ASH), 1st ed. Pharmacopeial Commission for Indian Medicine and Homeopathy, Ghaziabad

[22]

Minstry of Ayush (2017c) The Ayurvedic Pharmacopeia of India, Vol. IV Part II Appendix 2.2.5 (Water Soluble Extractive), 1st ed. Pharmacopeial Commission for Indian Medicine and Homeopathy, Ghaziabad

[23]

Minstry of Ayush (2017d) The Ayurvedic Pharmacopeia of India, Vol. IV Part II Appendix 2.2.6 (Alcohol Soluble Extractive), 1st ed., vol. Part II Volume IV. Pharmacopeial Commission for Indian Medicine and Homeopathy, Ghaziabad

[24]

Mun CS, Hui LY, Sing LC, Karunakaran R, Ravichandran V. Multi-targeted molecular docking, pharmacokinetics, and drug-likeness evaluation of coumarin based compounds targeting proteins involved in development of COVID-19. Saudi J Biol Sci, 2022, 2912103458

[25]

O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: an open chemical toolbox. J Cheminformatics, 2011, 3133.

[26]

PEAKS Online - Bioinformatics Solutions Inc. Accessed 25 July 2026. [Online]. Available: https://www.bioinfor.com/peaks

[27]

PubChem. Accessed 25 July 2026. [Online]. Available: https://pubchem.ncbi.nlm.nih.gov/

[28]

Rai P, Garain T, Gupta D. Phytochemical analysis of Tinospora cordifolia and Withania somnifera and their therapeutic activities with special reference to COVID-19. World J Exp Med, 2024, 143p. 95512

[29]

Rana V, Thakur K, Sood R, Sharma V, Sharma TR. Genetic diversity analysis of Tinospora cordifolia germplasm collected from northwestern Himalayan region of India. J Genet, 2012, 91199103.

[30]

Ravan (Chowkhamba or Khemraj Shri Krishnadass Sanskrit-Hindi editions), “Arka Prakasha (Arkaprakāśa),” Chowkhamba Sanskrit Series Office, ch. 2 (Sloka 2–31), pp 21–22

[31]

Saha S, Ghosh S. Tinospora cordifolia: one plant, many roles. Anc Sci Life, 2012, 314151.

[32]

Sangeetha MK, Raghavendran HRB, Gayathri V, Vasanthi HR. Tinospora cordifolia attenuates oxidative stress and distorted carbohydrate metabolism in experimentally induced type 2 diabetes in rats. J Nat Med, 2011, 653–4544550.

[33]

Singh AK, Kumar S, Kumari P, Tiwari SN, Scholar PG. A pharmaceutical standardization of Guduchi (Tinospora cordifolia). Int J Ayurveda Pharma Res, 2023.

[34]

SwissTargetPrediction. Accessed 25 July 2026. [Online]. Available: https://www.swisstargetprediction.ch/

[35]

Tiwari P, Nayak P, Prusty SK, Sahu K. Phytochemistry and pharmacology of Tinospora cordifolia: a review. Syst Rev Pharm, 2018.

[36]

Tripathi I. Arka prakash of Lankapati Ravan, 20062nd ed.VaranasiChowkhamba Sanskrit Series Officevol. 3

[37]

Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimisation, and multithreading. J Comput Chem, 2010, 312455461.

Funding

CCRAS: Central Council for Research in Ayurvedic Sciences(CCRAS: Central Council for Research in Ayurvedic Sciences)

Rights & permissions

The Author(s)

PDF

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉